There is a lot of excitement about a new drug for women suffering from postpartum depression, but Sage Therapeutics’ Zulresso will present challenges for medical coders, their employers, and patients. First Postpartum Depression Drug Zulresso is the first drug developed specifically for postpartum depression. Often un or misdiagnosed, postpartum depression (F33.0), affects an estimated national […]
The post Postpartum Drug Challenges Medical Coders appeared first on AAPC Knowledge Center.